Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Feb 05, 2021
The Best Investment Advice You'll Ever Get

The Best Investment Advice You'll Ever Get

The best investment advice you'll ever receive is not a new, exciting, cutting-edge secret that you were probably hoping for. It's quite the opposite, actually. The best advice is the yawn-inspiring, time-tested, 'effective-since-the-advent-of-the-stock market' approach, and it's no secret.

It's diversification.

I know what you're thinking: quit wasting my time with this boring stuff! And I get it - you've probably heard the 'diversification' bit a million times. But I'd argue that the concept of diversification isn't boring at all. Boring to me is watching C-Span for 16 hours straight. Diversification is different: it's actually more challenging than it is boring, for two very critical reasons.

Reason #1: Everyone Knows Diversification is the Answer, But Very Few People Know How to Properly Diversify

This is the equivalent of everyone knowing that eating healthy leads to a more healthy (and perhaps longer) life, but few people know what to actually eat and how to organize healthy meals. Investing is very similar. Most folks know that a well-diversified portfolio can lead to strong risk-adjusted returns over time, but few actually know how to build the diversified portfolio in the first place. What if there were easy-to-use technology that could give you ideas for how to build a diversified portfolio yourself?? (spoiler alert: it exists right now, at tickeron.com)

Reason #2: Investors Get In Their Own Way too Often

The second reason has more to do with human nature than anything else. Humans are hard-wired to be wary of risk and to make emotional decisions, especially when fear is involved. And make no mistake - there is plenty of fear in the stock market. All too often, investors will see something on the news that causes them to make a significant asset allocation adjustment, such as selling a big portion of stocks. But that's a major folly: diversification works if you stick with it for the long-term, but many investors have difficulty with that. That's why it makes sense for investors to acknowledge your weakness where it exists, and use the help of a Financial Advisor or the A.I. at Tickeron, to keep you on track. Take the decision-making process out of your hands a bit, and allow experts to do more of the work.

JP Morgan released some research recently that underscores the importance and the value of diversification. From 2001 - 2015, they analyzed two different portfolios. The more diversified portfolio, I'll call it Portfolio #1, had exposure to eight different asset categories: S&P 500, Russell 2000, REITs, EAFE Equity, Emerging Market Equity, Barclays Aggregate Bonds, US High Yield Bonds, and Emerging Markets Debt.

The second portfolio, Portfolio #2, had exposure to only three asset categories: S&P 500, EAFE Equity, and Barclays Aggregate Bonds.

Guess which portfolio performed better over the 15-year period?? You guessed it: Portfolio #1, the more diversified portfolio. It delivered annualized returns of 6.2%, compared to the less diversified portfolio which delivered returns of 5.4%.

Diversification makes a difference and history tells us that it works. The challenge facing investors today is knowing how to diversify, and where to invest assets. But it doesn't have to be a challenge any longer - you can generate ideas right here at tickeron.com.  

Related Ticker: ACWI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ACWI's Stochastic Oscillator is sitting in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ACWI moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ACWI crossed bullishly above the 50-day moving average on August 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACWI advanced for three days, in of 356 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ACWI moved out of overbought territory on August 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACWI as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ACWI turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACWI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACWI broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ACWI entered a downward trend on August 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Microsoft Corp (NASDAQ:MSFT), Amazon.com (NASDAQ:AMZN), Broadcom Inc. (NASDAQ:AVGO), Tesla (NASDAQ:TSLA), Meta Platforms (NASDAQ:META), Eli Lilly & Co (NYSE:LLY).

Industry description

The investment seeks to track the investment results of the MSCI ACWI composed of large- and mid-capitalization developed and emerging market equities. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization weighted index designed to measure the combined equity market performance of developed and emerging markets countries.

Market Cap

The average market capitalization across the iShares MSCI ACWI ETF ETF is 137.87B. The market cap for tickers in the group ranges from 64.65K to 5.2T. NVDA holds the highest valuation in this group at 5.2T. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI ACWI ETF ETF was 115%. For the same ETF, the average monthly price growth was 157%, and the average quarterly price growth was 252%. MRNA experienced the highest price growth at 129%, while ALA experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI ACWI ETF ETF was 15%. For the same stocks of the ETF, the average monthly volume growth was -18% and the average quarterly volume growth was -36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 54
Price Growth Rating: 45
SMR Rating: 54
Profit Risk Rating: 61
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
ACWI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Details
Category
Global Large-Stock Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
The Best Investment Advice You'll Ever Get